INFANRIX® DTaP 0.5 ml SDV
INFANRIX® DTaP 0.5 ml SDV INFANRIX® DTaP 0.5 ml Syringe

INFANRIX® DTaP

Be the first to review this product

Physician's authorization is required to purchase this item. Physician's authorization is required to purchase this item.


INFANRIX (Diphtheria and Tetanus Toxoids and Acellular Pertussis Vaccine Adsorbed) is a noninfectious, sterile vaccine for intramuscular administration. Each 0.5-mL dose is formulated to contain 25 Lf of diphtheria toxoid, 10 Lf of tetanus toxoid, 25 mcg of inactivated pertussis toxin (PT), 25 mcg of filamentous hemagglutinin (FHA), and 8 mcg of pertactin (69 kiloDalton outer membrane protein).

The diphtheria toxin is produced by growing Corynebacterium diphtheriae in Fenton medium containing a bovine extract. Tetanus toxin is produced by growing Clostridium tetani in a modified Latham medium derived from bovine casein. The bovine materials used in these extracts are sourced from countries which the United States Department of Agriculture (USDA) has determined neither have nor present an undue risk for bovine spongiform encephalopathy (BSE). Both toxins are detoxified with formaldehyde, concentrated by ultrafiltration, and purified by precipitation, dialysis, and sterile filtration.

The acellular pertussis antigens (PT, FHA, and pertactin) are isolated from Bordetella pertussis culture grown in modified Stainer-Scholte liquid medium. PT and FHA are isolated from the fermentation broth; pertactin is extracted from the cells by heat treatment and flocculation. The antigens are purified in successive chromatographic and precipitation steps. PT is detoxified using glutaraldehyde and formaldehyde. FHA and pertactin are treated with formaldehyde.

Diphtheria and tetanus toxoids and pertussis antigens (PT, FHA, and pertactin) are individually adsorbed onto aluminum hydroxide.

Diphtheria and tetanus toxoid potency is determined by measuring the amount of neutralizing antitoxin in previously immunized guinea pigs. The potency of the acellular pertussis components (PT, FHA, and pertactin) is determined by enzyme-linked immunosorbent assay (ELISA) on sera from previously immunized mice.

Each 0.5-mL dose contains aluminum hydroxide as adjuvant (not more than 0.625 mg aluminum by assay) and 4.5 mg of sodium chloride. Each dose also contains ≤100 mcg of residual formaldehyde and ≤100 mcg of polysorbate 80 (Tween 80).

INFANRIX is available in vials and 2 types of prefilled syringes. One type of prefilled syringe has a tip cap which may contain natural rubber latex and a plunger which does not contain latex. The other type has a tip cap and a rubber plunger which contain dry natural latex rubber. The vial stopper does not contain latex.
Item Name INFANRIX® DTaP
Specifications No
Brand GlaxoSmithKline
HCPCS No
Free Shipping No
Warning

Physician's authorization is required to purchase this item. Physician's authorization is required to purchase this item.

User Manual N/A
Brochure N/A
MSDS N/A
OR
SKU Image Item Name PKG Availability Price Qty
58160-810-11 INFANRIX® DTaP 0.5 ml SDV INFANRIX® DTaP 0.5 ml SDV 10/BX

Usually in Stock - Ships within 1-2 Days

$259.95
58160-810-52 INFANRIX® DTaP 0.5 ml Syringe INFANRIX® DTaP 0.5 ml Syringe 10/BX

Usually in Stock - Ships within 1-2 Days

$269.95